FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ghebremariam, Yohannes T ^a   Yamada, Keisuke ^a   Lee, Jerry C ^a   Johnson, Christine L C ^b   Atzler, Dorothee ^c   Anderssohn, Maike ^c   Agrawal, Rani ^b   Higgins, John P ^b   Patterson, Andrew J ^c   Böger, Rainer H ^c   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLARGININASE; OBETICHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HEART RATE; HYPERTENSION; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

AMIDOHYDROLASES; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CHENODEOXYCHOLIC ACID; DIET; GENE EXPRESSION REGULATION; HYPERTENSION; INSULIN RESISTANCE; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; MALE; NITRIC OXIDE; ORGAN SIZE; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SODIUM CHLORIDE, DIETARY;

MUS; RATTUS;

EID: 84875939618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060653     Document Type: Article

References (61)

1. Sanada H, Jones JE, Jose PA, (2011) Genetics of salt-sensitive hypertension. Curr Hypertens Rep 13: 55-66.
2. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP, (2009) Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. Bmj 339: b4567.
3. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, et al. (2009) Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54: 475-481.
4. He FJ, MacGregor GA, (2010) Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 52: 363-382.
5. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, et al. (1998) Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 24: 296-301.
6. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, et al. (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344: 3-10.
7. Cooke JP, Ghebremariam YT, (2011) Dietary nitrate, nitric oxide, and restenosis. J Clin Invest 121: 1258-1260.
8. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, et al. (2002) The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39: 919-922.
9. Miyaki K, Tohyama S, Murata M, Kikuchi H, Takei I, et al. (2005) Salt intake affects the relation between hypertension and the T-786C polymorphism in the endothelial nitric oxide synthase gene. Am J Hypertens 18: 1556-1562.
10. Dengel DR, Brown MD, Ferrell RE, Reynolds TH, Supiano MA, (2007) A preliminary study on T-786C endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure responses to dietary sodium. Physiol Res 56: 393-401.
11. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M, (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222.
12. Siekmeier R, Grammer T, Marz W, (2008) Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function. J Cardiovasc Pharmacol Ther 13: 279-297.
13. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, et al. (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104: 342-345.
14. Hodge G, Ye VZ, Duggan KA, (2002) Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat. Exp Physiol 87: 1-8.
15. Baron AD, (1996) Insulin and the vasculature - old actors, new roles. J Investig Med 44: 406-412.
16. Reaven GM, (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
17. Reaven G, (2005) Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation 112: 3030-3032.
18. Cooke JP, (2000) The endothelium: a new target for therapy. Vasc Med 5: 49-53.
19. Baron AD, (1999) Vascular reactivity. Am J Cardiol 84: 25J-27J.
20. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD, (2000) Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49: 684-687.
21. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, et al. (2002) Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. Jama 287: 1420-1426.
22. Fang Y, Mu JJ, He LC, Wang SC, Liu ZQ, (2006) Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 48: 724-729.
23. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, et al. (2000) Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 101: 856-861.
24. Cooke JP, (2004) Asymmetrical dimethylarginine: the Uber marker? Circulation 109: 1813-1818.
25. Palm F, Onozato ML, Luo Z, Wilcox CS, (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293: H3227-3245.
26. Hu X, Atzler D, Xu X, Zhang P, Guo H, et al. (2011) Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol 31: 1540-1546.
27. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, et al. (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104: 2569-2575.
28. Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP, (2008) Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 28: 692-697.
29. Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, et al. (2003) Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108: 3042-3047.
30. Dahl LK, Heine M, Tassinari L, (1962) Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115: 1173-1190.
31. Rapp JP, Dene H, (1985) Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7: 340-349.
32. Li J, Wilson A, Gao X, Kuruba R, Liu Y, et al. (2009) Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J Pharmacol Exp Ther 331: 234-243.
33. Hu T, Chouinard M, Cox AL, Sipes P, Marcelo M, et al. (2006) Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. J Biol Chem 281: 39831-39838.
34. Mookerjee RP, (2011) Acute-on-chronic liver failure: the liver and portal haemodynamics. Curr Opin Crit Care 17: 170-176.
35. Mondon CE, Dolkas CB, Oyama J, (1981) Enhanced skeletal muscle insulin sensitivity in year-old rats adapted to hypergravity. Am J Physiol 240: E482-488.
36. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, et al. (2004) Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42: 1377-1383.
37. Maas R, Tan-Andreesen J, Schwedhelm E, Schulze F, Boger RH, (2007) A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. J Chromatogr B Analyt Technol Biomed Life Sci 851: 220-228.
38. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, et al. (1997) Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 29: 242-247.
39. Shehata MF, (2008) Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats. Cardiovasc Diabetol 7: 7.
40. Ogihara T, Asano T, Ando K, Sakoda H, Anai M, et al. (2002) High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40: 83-89.
41. Li J, White J, Guo L, Zhao X, Wang J, et al. (2009) Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 139: 447-451.
42. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, et al. (2007) Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A 104: 16281-16286.
43. Tzemos N, Lim PO, Wong S, Struthers AD, MacDonald TM, (2008) Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 51: 1525-1530.
44. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA, (2010) Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 1802: 1259-1267.
45. He FJ, MacGregor GA, (2009) A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 23: 363-384.
46. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T, (1993) Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22: 49-55.
47. Burg MB, (1982) Thick ascending limb of Henle's loop. Kidney Int 22: 454-464.
48. Stoos BA, Garcia NH, Garvin JL, (1995) Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6: 89-94.
49. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T, (1992) Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20: 113-117.
50. Chen PY, Sanders PW, (1991) L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88: 1559-1567.
51. Wang D, Strandgaard S, Iversen J, Wilcox CS, (2009) Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 296: R195-200.
52. Cooke JP, (2010) DDAH: a target for vascular therapy? Vasc Med 15: 235-238.
53. Ghebremariam YT, Erlanson DA, Yamada K, Cooke JP, (2012) Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening. J Biomol Screen 17: 651-661.
54. Chitturi S, George J, (2003) Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 5: 18-25.
55. Wang XX, Jiang T, Shen Y, Adorini L, Pruzanski M, et al. (2009) The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol 297: F1587-1596.
56. Wang XX, Jiang T, Shen Y, Caldas Y, Miyazaki-Anzai S, et al. (2010) Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 59: 2916-2927.
57. Miyazaki-Anzai S, Levi M, Kratzer A, Ting TC, Lewis LB, et al. (2010) Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease. Circ Res 106: 1807-1817.
58. Vairappan B, Sharma V, Winstanley A, Davies N, Shah N, et al. (2009) Modulation of the DDAH-ADMA pathway with the farnesoid x receptor (FXR) agonist INT-747 restores hepatic eNOS activity and lowers portal pressure in cirrhotic rats. Hepatology; 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases:336A-337A.
59. Cariou B, Duran-Sandoval D, Kuipers F, Staels B, (2005) Farnesoid X receptor: a new player in glucose metabolism? Endocrinology 146: 981-983.
60. Staels B, Kuipers F, (2007) Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 67: 1383-1392.
61. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10: 167-177.